Tsfg, LLC Viatris Inc Transaction History

Tsfg, LLC

$397 Million
Q1 2024

A detailed history of Tsfg, LLC transactions in Viatris Inc stock. As of the latest transaction made, Tsfg, LLC holds 705 shares of VTRS stock, worth $7,353. This represents 0.0% of its overall portfolio holdings.

Number of Shares

705

Previous 752 6.25%

Holding current value

$7,353

Previous $8,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 16, 2024	SELL	$11.27 - $13.53 $529 - $635	-47 Reduced 6.25%	705 $8,000
Q4 2023 Jan 23, 2024	SELL	$8.77 - $10.85 $306 - $379	-35 Reduced 4.45%	752 $8,000
Q3 2023 Oct 10, 2023	BUY	$9.59 - $11.35 $364 - $431	38 Added 5.07%	787 $8,000
Q2 2023 Jul 10, 2023	SELL	$9.02 - $10.29 $117 - $133	-13 Reduced 1.71%	749 $7,000
Q1 2023 Apr 21, 2023	BUY	$9.2 - $12.26 $27 - $36	3 Added 0.4%	762 $7,000

Q4 2022 Jan 19, 2023	SELL	$8.72 - $11.56 $348 - $462	-40 Reduced 5.01%	759 $8,000
Q3 2022 Oct 20, 2022	SELL	$8.48 - $11.13 $992 - $1,302	-117 Reduced 12.77%	799 $7,000
Q2 2022 Jul 13, 2022	SELL	$9.95 - $12.27 $308 - $380	-31 Reduced 3.27%	916 $10,000
Q1 2022 Apr 25, 2022	BUY	$9.81 - $15.4 $9 - $15	1 Added 0.11%	947 $10,000
Q4 2021 Feb 10, 2022	BUY	$12.09 - $14.68 $2,127 - $2,583	176 Added 22.86%	946 $13,000
Q3 2021 Oct 12, 2021	BUY	$13.25 - $15.13 $13 - $15	1 Added 0.13%	770 $10,000
Q2 2021 Jul 19, 2021	BUY	$12.97 - $16.15 $155 - $193	12 Added 1.59%	769 $11,000
Q1 2021 Apr 14, 2021	SELL	$13.59 - $18.54 $1,277 - $1,742	-94 Reduced 11.05%	757 $11,000
Q4 2020 Jan 20, 2021	BUY	$14.3 - $18.74 $12,169 - $15,947	851 New	851 $16,000

Others Institutions Holding VTRS

# of Institutions

1,098

Shares Held

945M

Call Options Held

3.49M

Put Options Held

2.6M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $12.6B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tsfg, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tsfg, LLC with notifications on news.

Account